SOT (Short Oligonucleotide Therapy)
What is it and how does it work?
SOT is a therapy by which cancer-causing genes are silenced and prevented from replicating. With this treatment, a person’s specific genes are analyzed, the cancer-causing mutations are identified, and a specific, individualized treatment is created to “inactivate” those genes that are causing uncontrolled replication of the cancer cells.
The RGCC lab located in Greece has developed a process that enables them to identify the specific gene sequences of different targets such as cancer, Lyme disease, and viruses.
- The term “gene sequences” refers to specific sections of DNA that encode for the production of specific proteins that determine how cells function and replicate.
- The information stored in DNA is communicated to the cells via strands of genetic material called mRNA (messenger RNA). This mRNA dictates which proteins are made by the cells.
- Normal cells (with healthy DNA and proteins) contain mechanisms that tightly control cellular replication, ensuring that those cells that are cancerous, infected, or otherwise unhealthy are destroyed and do not get propagated.
- Mutations in the DNA can lead to the production of harmful proteins that cause disease, including cancer. Cancer cells lack the “controls” associated with proper replication and this leads to unchecked, uncontrolled growth.
- SOT targets the mRNA associated with cancer cells by binding to specific sequences, rendering them incapable of making the proteins necessary for replication.
- This causes the cancer cells to die without being able to make more cancer cells. The process by which they die is known as “apoptosis.”
For more information on how oligonucleotide therapy works
How it works
SOT for Cancer
SOT for Lymes
Your blood is sent to the RGCC lab in Greece. There, circulating tumor cells will be isolated and analyzed. Your specific cancer-causing genes are specifically identified, and once identified the laboratory creates a complementary genetic sequence that can “bind” to and inactivate the abnormal mRNA.
These sequences will then be replicated to 500million –1 billion copies. Once this process is complete, they are shipped to our clinic where you will receive them via one dose of IV treatment.
Once these molecules enter your bloodstream, they continue to work on preventing cancer cell replication 24 hours a day, 7 days a week, for up to 6 months.
This therapy has also been shown to be very effective for Lyme disease and other chronic viral infections such as EBV (Epstein Barr Virus) and HPV (Human Papillomavirus).
It is important to note that this is not an immune treatment and does not work through immune activation the way that vaccines do. For this reason, there are usually minimal side effects. However, this therapy can lead to symptoms associated with the “die-off” of cancer cells. These include headaches, increased fatigue, pain at the surgical site of the cancer, and flu-like symptoms.